FDA Sued by Health Advocates Over High Cost of Harvoni
The efficacy and effectiveness of Harvoni in the treatment of hepatitis C is not at issue. But its cost is: a single treatment regimen, which involves taking one Harvoni pill per day, costs $94,000. While insurance companies generally are not allowed to deny a claimant due medication as prescribed, they can seek less expensive alternatives. The problem is there is no real alternative to Harvoni other than its close cousin, Sovaldi, which is almost as expensive.
The Journal of the American Medical Association says that new therapies are achieving hepatitis C cure rates higher than 95%.
When someone is cured of Hep C, they can’t infect anyone else by sharing a needle or having sex. Given the predatory nature of Big Pharma, I don’t think it’s at all cynical to suspect that drug companies have priced Harvoni and Solvadi so that only the wealthy can be cured, while the remainder of those who have hepatitis C suffer, infect others (who are hopefully wealthy), and then die.
Please sign the petition from the link below; let’s put some pressure on Gilead, and see what comes of it. If it goes viral, it’ll likely work faster than the lawsuit that’s been filed. Thank you.